The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Clinical Complications of Chemotherapy and Patient-Reported Outcomes After Breast Reconstruction
Aging Cancer Survivors Have Greater Functional Decline
Artificial Intelligence and Mammography
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Genital Powder Use and Epithelial Ovarian Cancer
No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
Oral Contraceptives May Reduce Risk of Ovarian Cancer in BRCA Carriers
Women’s Health: 50 Years of Progress
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Combination Strategies Reshape Treatment Paradigm for Advanced Endometrial Cancer
Blood Test for Many Cancer Types as Supplement to Screening
Use of Hair Products in Relation to Ovarian Cancer Risk
Cognitive Function After Cancer and Cancer Treatment
Association Between Breastfeeding and Ovarian Cancer Risk
Women With Ovarian Cancer at Higher Risk for Mental Health Disorders
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Drug Boosts Survival for Women with Advanced Ovarian Cancer
Short-term Impact of Surgically Induced Menopause on Cognitive Function and Wellbeing